Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Small Cap Growth Fund” second-quarter ...

Greenhaven Road Capital, an investment management company, released its second-quarter 2025 investor letter. A copy of the ...

Cellebrite (CLBT) boasts strong growth potential with robust financials, digital forensics leadership, and a durable moat.

Investors in Cellebrite DI Ltd (Symbol: CLBT) saw new options become available this week, for the May 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

On November 14, 2024, Cellebrite DI Ltd. (NASDAQ:CLBT) stock closed at $17.96 per share with a market capitalization of $3.859 billion.

NU currently has a forward P/E ratio of 37.15, while CLBT has a forward P/E of 44.66. We also note that NU has a PEG ratio of 0.69. This popular metric is similar to the widely-known P/E ratio ...

For comparison, CLBT has a P/B of 12.85. These are just a few of the metrics contributing to NU's Value grade of B and CLBT's Value grade of D.

Cellebrite DI Ltd. (CLBT) key stats comparison: compare with other stocks by metrics: valuation, growth, profitability, momentum, EPS revisions, dividends, ratings.